Association of broad-spectrum antibiotic use with faecal carriage of oxyiminocephalosporin-resistant enterobacteriaceae in an intensive care unit

Journal of Hospital Infection

Volumn 63, Issue 3, 2006, Pages 306-315

  Vignoli, R ^a   Calvelo, E ^a   Cordeiro, N F ^a   Lucero, R ^a   Ingold, E ^a   Quintana, A ^a,b   del Monte, A ^a   Schelotto, F ^a  

^a Medicine Faculty   (Uruguay)

^b HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

Antibiotic resistance; ESBL

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; OXYIMINOCEPHALOSPORIN; SULBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; ENTEROBACTERIACEAE; FECES ANALYSIS; FISHER EXACT TEST; HUMAN; INTENSIVE CARE; SAMPLING; STANDARDIZATION;

ANTI-BACTERIAL AGENTS; BURN UNITS; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; ENTEROBACTERIACEAE; FECES; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 33744545691     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2005.12.017     Document Type: Article

References (27)

1. Cantón R., Oliver A., Coque T.M., Varela M.C., Pérez-Díaz J.C., and Baquero F. Epidemiology of extended-spectrum β-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. J Clin Microbiol 40 (2002) 1237-1243
2. Navon-Venezia S., Hammer-Munz O., Schwartz D., et al. Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv medical center (Israel) and evaluation of diagnostic test. J Clin Microbiol 41 (2003) 155-158
3. Nierop W.H., Duse A.G., Stewart R.G., Bilgeri Y.R., and Koornhof H.J. Molecular epidemiology of an outbreak of Enterobacter cloacae in the neonatal intensive care unit of a provincial hospital in Gauteng, South Africa. J Clin Microbiol 36 (1998) 3085-3087
4. Lucet J.C., Chevres S., Decré D., et al. Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 22 (1996) 430-436
5. Spanu T., Luzzaro F., Perilli M., et al. Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to β-lactams and other antimicrobial drugs. Antimicrob Agents Chemother 46 (2002) 196-202
6. Kim Y.K., Pai H., Lee H.J., et al. Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 46 (2002) 1481-1491
7. Martone W.J., Jarvis W.R., Edwards J.R., et al. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennet J.V., and Brachman P.S. (Eds). Hospital infection. 4th edn. (1998), Little, Brown and Co., Boston
8. Peña C., Pujol M., Ardanuy C., et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 42 (1998) 53-58
9. Asensio A., Oliver A., González-Diego P., et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 30 (2000) 55-60
10. Peña C., Pujol M., Ricart A., et al. Risk factors for fecal carriage of Klebsiella pneumoniae producing extended-spectrum β-lactamases in the intensive care unit. J Hosp Infect 35 (1997) 9-16
11. Kaye K.S., Cosgrove S., Harris A., Eliopoulos G.M., and Carmeli Y. Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother 45 (2001) 2628-2630
12. Ambler R.P., and Scott G.K. The structure of β-lactamases. Philos Trans R Soc Lond B Biol Sci 289 (1980) 321-331
13. Farmer J.J. Enterobacteriaceae: introduction and identification. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds). Manual of clinical microbiology. 7th edn. (1999), American Society for Microbiology, Washington DC 442-458
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disks susceptibility tests. 7th edn. Approved standard M2-A7. Ferraro, MJ: NCCLS; 2000.
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 11th Informational Supplement M100-S11. Ferraro, MJ: NCCLS; 2001.
16. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th edn. Approved standard M7-A5. Ferraro, MJ: NCCLS; 2000.
17. Thomson K.S., and Smith-Moland E. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing enterobacteriaceae. Antimicrob Agents Chemother 45 (2001) 3548-3554
18. Arbeit R.D. Laboratory procedures for the epidemiologic analysis of microorganisms. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds). Manual of clinical microbiology. 6th edn. (1995), American Society for Microbiology, Washington, DC 190-208
19. Vollrath D. Resolving multimegabase DNA molecules using contour-clamped homogeneous electric fields (CHEF). In: Burmeister M., and Ulanovsky L. (Eds). Pulsed-field gel electrophoresis. Protocols, methods and theories. Methods in molecular biology (1992), Humana Press, Totowa, NJ Vol. 12, pp. 19-30
20. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
21. Vignoli R., Varela G., Imota M., et al. Enteropathogenic Escherichia coli (EPEC) strains carrying PER-2 and TEM 116 extended spectrum β-lactamase (ESBL) isolated from children with diarrhea in Uruguay. J Clin Microbiol 43 (2005) 2940-2943
22. Power P., Radice M., Barberis C., et al. Cefotaxime-hydrolysing β-lactamases in Morganella morganii. Eur J Clin Microbiol Infect Dis 18 (1999) 743-747
23. Rossi A., Lopardo H., Woloj M., et al. Non-typhoid Salmonella spp. resistant to cefotaxime. J Antimicrob Chemother 36 (1995) 697-702
24. Legrand P., Fournier G., Buré A., et al. Detection of extended broad-spectrum β-lactamases in enterobacteriaceae in four French hospitals. Eur J Clin Microbiol Infect Dis 8 (1989) 527-529
25. Pérez-Pérez F.J., and Hanson N.D. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40 (2002) 2153-2162
26. Sakata H., Fujita K., and Yoshioka H. The effect of antimicrobial agents on fecal flora of children. Antimicrob Agents Chemother 29 (1986) 225-229
27. Bauernfeind A., Stemplinger I., Jungwirth R., et al. Characterization of β-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase. Antimicrob Agents Chemother 40 (1996) 616-620